Drug
S 606001
S 606001: highest development phase Phase 2, developed by Shionogi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| S-606001 NCT07750990 | Phase 2 | Pompe Disease |
| S-606001 NCT07787650 | Phase 1 | Pompe Disease |
Latest
No recent events.
Follow S 606001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.